- Home
- Publications
- Publication Search
- Publication Details
Title
Shp1 in Solid Cancers and Their Therapy
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-11
DOI
10.3389/fonc.2020.00935
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Euxanthone represses the proliferation, migration, and invasion of glioblastoma cells by modulating STAT3/SHP‐1 signaling
- (2020) Wen Li et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1
- (2020) Hai Zhang et al. Cell Death & Disease
- Inhibition of SHP-1 expands the repertoire of antitumor T cells available to respond to immune checkpoint blockade
- (2020) Jeremy P. Snook et al. Cancer Immunology Research
- Lifting the innate immune barriers to antitumor immunity
- (2020) Carla V Rothlin et al. Journal for ImmunoTherapy of Cancer
- Aberrant promoter�2 methylation‑mediated downregulation of protein tyrosine phosphatase, non‑receptor type�6, is associated with progression of esophageal squamous cell carcinoma
- (2019) Lei Liu et al. Molecular Medicine Reports
- A signalling cascade involving receptor-activated phospholipase A2, glycerophosphoinositol 4-phosphate, Shp1 and Src in the activation of cell motility
- (2019) Alessia Varone et al. Cell Communication and Signaling
- Regulation of peripheral and central immunity: Understanding the role of Src homology 2 domain-containing tyrosine phosphatases, SHP-1 & SHP-2
- (2019) Manika Garg et al. IMMUNOBIOLOGY
- Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma
- (2019) Sarita Saraswati et al. Cell Communication and Signaling
- Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells
- (2018) Sung Ho Kim et al. BMC CANCER
- Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma
- (2018) Huinan Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Inhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducer
- (2018) Jin Sung Koh et al. Cell and Bioscience
- Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma
- (2017) Kai Ding et al. International Journal of Clinical Oncology
- Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy
- (2017) Tzu-Ting Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma”
- (2017) Wei-Tien Tai et al. JOURNAL OF HEPATOLOGY
- T Cells Deficient in the Tyrosine Phosphatase SHP-1 Resist Suppression by Regulatory T Cells
- (2017) Emily R. Mercadante et al. JOURNAL OF IMMUNOLOGY
- Shp1 function in myeloid cells
- (2017) Clare L. Abram et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells
- (2017) Chun-Yu Liu et al. Molecular Oncology
- SHP-1: the next checkpoint target for cancer immunotherapy?
- (2016) H. Angharad Watson et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma
- (2016) Yan Sheng et al. GYNECOLOGIC ONCOLOGY
- Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma
- (2016) Jing Liu et al. ONCOLOGY REPORTS
- Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition
- (2016) Tao Zhang et al. Cell Death & Disease
- Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer
- (2016) Li-Ching Fan et al. Oncotarget
- Global Promoter Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes in Natural Killer Cell Lymphoma
- (2015) C. Kucuk et al. CLINICAL CANCER RESEARCH
- Antitumorigenic effect of plumbagin by induction of SH2-containing protein tyrosine phosphatase 1 in human gastric cancer cells
- (2015) MOON KYUNG JOO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- SHP-1 is a negative regulator of epithelial–mesenchymal transition in hepatocellular carcinoma
- (2015) L-C Fan et al. ONCOGENE
- Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells
- (2015) Moon Kyung Joo et al. TUMOR BIOLOGY
- LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
- (2015) Ruea-Yea Huang et al. Oncotarget
- SHP-1 is a target of regorafenib in colorectal cancer
- (2015) Li-Ching Fan et al. Oncotarget
- Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
- (2014) Kodappully Sivaraman Siveen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Small molecule 1′-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway
- (2014) Jieqiong Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- STAT3 Mediates Regorafenib-Induced Apoptosis in Hepatocellular Carcinoma
- (2014) W.-T. Tai et al. CLINICAL CANCER RESEARCH
- Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia
- (2014) YINGHUA LI et al. ONCOLOGY REPORTS
- The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling
- (2013) Elena Tibaldi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Lessons from the Cancer Genome
- (2013) Levi A. Garraway et al. CELL
- Characterization of SHP-1 protein tyrosine phosphatase transcripts, protein isoforms and phosphatase activity in epithelial cancer cells
- (2013) Sevan Evren et al. GENOMICS
- Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma
- (2013) Wei-Tien Tai et al. HEPATOLOGY
- Erratum to: The role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable stage I non-small cell lung cancer as a prognostic marker of disease recurrence
- (2013) Chanida Vinayanuwattikun et al. International Journal of Clinical Oncology
- Incidence and prognostic value of multiple gene promoter methylations in gliomas
- (2013) Longzhou Zhang et al. JOURNAL OF NEURO-ONCOLOGY
- Epigenetic mechanisms of protein tyrosine phosphatase 6 suppression in diffuse large B-cell lymphoma: implications for epigenetic therapy
- (2013) T E Witzig et al. LEUKEMIA
- SHP-1 in Cell-Cycle Regulation
- (2012) Pilar Lopez-Ruiz et al. Anti-Cancer Agents in Medicinal Chemistry
- Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1
- (2012) Subash C. Gupta et al. BIOCHEMICAL PHARMACOLOGY
- Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
- (2012) Aruljothi Subramaniam et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
- (2012) Matthias T. Stephan et al. BIOMATERIALS
- Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity
- (2012) Kuen-Feng Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Abrogation of Src Homology Region 2 Domain-Containing Phosphatase 1 in Tumor-Specific T Cells Improves Efficacy of Adoptive Immunotherapy by Enhancing the Effector Function and Accumulation of Short-Lived Effector T Cells In Vivo
- (2012) I. M. Stromnes et al. JOURNAL OF IMMUNOLOGY
- Hypermethylation of SHP-1 promoter in patient with high-risk myelodysplastic syndrome and it predicts poor prognosis
- (2012) Yizhuo Zhang et al. MEDICAL ONCOLOGY
- Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid Tumors
- (2012) Aung Naing et al. Journal of Cancer
- Chemosensitization of tumors by resveratrol
- (2011) Subash C. Gupta et al. Annals of the New York Academy of Sciences
- Compartmentalized CDK2 is connected with SHP-1 and β-catenin and regulates insulin internalization
- (2011) Annie Fiset et al. CELLULAR SIGNALLING
- Src Homology Domain 2-containing Protein-tyrosine Phosphatase-1 (SHP-1) Binds and Dephosphorylates Gα-interacting, Vesicle-associated Protein (GIV)/Girdin and Attenuates the GIV-Phosphatidylinositol 3-Kinase (PI3K)-Akt Signaling Pathway
- (2011) Yash Mittal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation
- (2011) Wei Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
- (2011) Wei-Tien Tai et al. JOURNAL OF HEPATOLOGY
- Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-small Cell Lung Cancer
- (2011) Chanida Vinayanuwattikun et al. Journal of Thoracic Oncology
- Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia
- (2011) Seisho Takeuchi et al. LEUKEMIA RESEARCH
- Dovitinib Induces Apoptosis and Overcomes Sorafenib Resistance in Hepatocellular Carcinoma through SHP-1-Mediated Inhibition of STAT3
- (2011) W.-T. Tai et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
- (2010) K.-F. Chen et al. CLINICAL CANCER RESEARCH
- The Protein Tyrosine Phosphatase SHP-1 Modulates the Suppressive Activity of Regulatory T Cells
- (2010) T. Iype et al. JOURNAL OF IMMUNOLOGY
- 5-Hydroxy-2-Methyl-1,4-Naphthoquinone, a Vitamin K3 Analogue, Suppresses STAT3 Activation Pathway through Induction of Protein Tyrosine Phosphatase, SHP-1: Potential Role in Chemosensitization
- (2010) S. K. Sandur et al. MOLECULAR CANCER RESEARCH
- Sorafenib Induces Growth Arrest and Apoptosis of Human Glioblastoma Cells through the Dephosphorylation of Signal Transducers and Activators of Transcription 3
- (2010) Fan Yang et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib Inhibits STAT3 Activation to Enhance TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells
- (2010) S. Huang et al. MOLECULAR CANCER THERAPEUTICS
- Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors
- (2010) Luigi Insabato et al. ONCOLOGY
- SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels
- (2009) Ulrike Lorenz IMMUNOLOGICAL REVIEWS
- Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer
- (2009) Helena Tassidis et al. INTERNATIONAL JOURNAL OF CANCER
- Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery
- (2009) F J Rodríguez-Ubreva et al. ONCOGENE
- Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas
- (2008) K. Amara et al. ANNALS OF ONCOLOGY
- SRC-dependent signalling regulates actin ruffle formation induced by glycerophosphoinositol 4-phosphate
- (2008) Beatrice Maria Filippi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Evidence for a role of the Simian Virus 40 in human breast carcinomas
- (2008) M. Hachana et al. BREAST CANCER RESEARCH AND TREATMENT
- Protein tyrosine phosphatase inhibition induces anti-tumor activity: Evidence of Cdk2/p27kip1 and Cdk2/SHP-1 complex formation in human ovarian cancer cells
- (2008) Danielle Caron et al. CANCER LETTERS
- Guggulsterone, a Farnesoid X Receptor Antagonist, Inhibits Constitutive and Inducible STAT3 Activation through Induction of a Protein Tyrosine Phosphatase SHP-1
- (2008) K. S. Ahn et al. CANCER RESEARCH
- Activation of Cdk2 Stimulates Proteasome-dependent Truncation of Tyrosine Phosphatase SHP-1 in Human Proliferating Intestinal Epithelial Cells
- (2008) Mélanie Simoneau et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started